NEW YORK (dpa-AFX Broker) - The US investment bank Goldman Sachs has downgraded Carl Zeiss Meditec from "Neutral" to "Sell" and lowered the price target from 110 to 90 euros. After the poor first half of the year, the annual targets of the Jena-based company appear ambitious, wrote analyst Richard Felton in a study published on Thursday. The valuation also leaves little room for disappointment./ag/bek

Publication of the original study: 23.05.2024 / 05:06 / BST

First disclosure of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study